NIH-funded research R01 grant

Epitranscriptomic links to manganese-induced brain changes

Official title: Novel Epitranscriptomic Mechanisms in Metal Neurotoxicity

Funded at University of Georgia · NIH-11467973 · Data updated 2026-11-12

A study at the University of Georgia explores how manganese exposure changes brain cells at the molecular level, especially how a specific RNA reader protein responds and may contribute to movement-related brain problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Georgia
NIH-funded
Lab location1 site (Athens, United States)
Project startNovember 15, 2024
Project endOctober 31, 2029
Funding year2027
Award (this year)$444,880
NIH project number5R01ES036241-03
Project IDNIH-11467973 on NIH RePORTER

Who could benefit from this research

Could help

People with or at risk for manganese exposure or related neurotoxicity may benefit from future therapies informed by this research.

Less likely to help

The study is primarily basic science; direct benefits to patients may require further translational work.

What this research studies

This project focuses on how chronic manganese exposure affects the basal ganglia, with a look at astrocytes and their communication with neurons and microglia. It will examine how RNA modifications (m6A) and the YTHDF2 reader protein change in response to manganese and influence inflammatory processes. The researchers plan to uncover the molecular switches that shift astrocytes from a normal state to a pro-inflammatory state, potentially linking these changes to parkinsonism-like symptoms. The work combines cellular models and molecular methods to map how these epitranscriptomic changes drive neurotoxicity.

Why it matters

Potential benefit: If successful, findings could identify new targets to prevent or reduce manganese-related brain injury and movement disorders.

How similar studies have gone: Emerging evidence links RNA modifications to neurodegeneration, but the specific Mn-induced epitranscriptomic mechanisms are still being established.

Where this research is happening

  • University of Georgia
    Athens, United States
    Active

Researchers

  • Principal investigator: Kanthasamy, Anumantha Gounder — University of Georgia
  • Study coordinator: Kanthasamy, Anumantha Gounder

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.